Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
18.97
+0.07 (0.37%)
At close: Dec 5, 2025
4.58%
Market Cap 44.31B
Revenue (ttm) 84.74B
Net Income (ttm) 3.26B
Shares Out n/a
EPS (ttm) 2.01
PE Ratio 13.57
Forward PE 14.57
Dividend 0.88 (4.62%)
Ex-Dividend Date Aug 29, 2025
Volume 740,000
Average Volume 1,290,975
Open 18.83
Previous Close 18.90
Day's Range 18.77 - 18.99
52-Week Range 15.76 - 20.40
Beta 0.29
RSI 42.89
Earnings Date Mar 16, 2026

About HKG:0874

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical apparatus, and healthcare products; research... [Read more]

Sector Healthcare
Founded 1997
Employees 28,048
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0874
Full Company Profile

Financial Performance

In 2024, HKG:0874's revenue was 74.99 billion, a decrease of -0.69% compared to the previous year's 75.52 billion. Earnings were 2.84 billion, a decrease of -30.09%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.